Linda Llewelyn - 04 Jan 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief People Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Issuer symbol
HCAT
Transactions as of
04 Jan 2022
Net transactions value
-$95,006
Form type
4
Filing time
06 Jan 2022, 20:07:56 UTC
Previous filing
07 Dec 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $22,140 +2,050 +6.6% $10.80 33,016 04 Jan 2022 Direct
transaction HCAT Common Stock Options Exercise $12,958 +1,100 +3.3% $11.78 34,116 04 Jan 2022 Direct
transaction HCAT Common Stock Sale $130,104 -3,234 -9.5% $40.23 30,882 04 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -1,100 -19% $0.000000 4,754 04 Jan 2022 Common Stock 1,100 $11.78 Direct F2
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -2,050 -23% $0.000000 6,920 04 Jan 2022 Common Stock 950 $10.80 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1.
F2 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.
F3 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.